Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

50.5K
Overview
50.5K
Cancer Vaccines01:30

Cancer Vaccines

852
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
852
Active versus Passive Immunity01:31

Active versus Passive Immunity

9.4K
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
9.4K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

3.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Standard Precaution01:26

Standard Precaution

2.6K
Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
2.6K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

747
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
747

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vaccination Against Serogroup B Meningococcal Disease: Current Status and Future Perspectives-A Consensus Document of the World Association for Infectious Diseases and Immunological Disorders (WAidid).

Vaccines·2026
Same author

The Strategic Plan for Tuberculosis Elimination and Equity in Australia 2026-2030.

Communicable diseases intelligence (2018)·2026
Same author

Posaconazole in Saliva: Feasibility of a Noninvasive Monitoring Approach in Immunocompromised Children.

The Pediatric infectious disease journal·2026
Same author

Effect of neonatal BCG vaccination on oral herpes in early childhood: A nested study within a randomised controlled trial.

Vaccine·2026
Same author

State of Vancomycin Dosing in Neonates: An Overview.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG·2026
Same author

Optimising COVID-19 episode identification using serology and PCR/rapid antigen testing: insights from the BRACE trial.

BMC infectious diseases·2026

Related Experiment Video

Updated: Dec 6, 2025

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

10.9K

BCG vaccination: An update on current Australian practices.

Jemma Wittner Taylor1, Nigel Curtis2, Justin Denholm3

  • 1BBNSc, MBBS, DTMH, Infectious Diseases Advanced Trainee, The Royal Melbourne Hospital, Vic.

Australian Journal of General Practice
|October 5, 2020
PubMed
Summary

The Bacille Calmette-Guérin (BCG) vaccine prevents tuberculosis (TB) in Australian children at high risk. While effective against severe childhood TB, its efficacy in adults varies, and it

More Related Videos

Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System
10:11

Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System

Published on: January 31, 2018

9.7K
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.4K

Related Experiment Videos

Last Updated: Dec 6, 2025

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

10.9K
Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System
10:11

Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System

Published on: January 31, 2018

9.7K
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.4K

Area of Science:

  • Immunology
  • Infectious Diseases
  • Public Health

Background:

  • The Bacille Calmette-Guérin (BCG) vaccine is a key tool for preventing tuberculosis (TB) infection and disease, particularly in regions with high TB incidence.
  • BCG vaccination is crucial for managing TB in vulnerable populations.

Purpose of the Study:

  • To review the current applications of BCG vaccination in Australia.
  • To detail indications, contraindications, efficacy, and off-target effects of BCG.
  • To clarify the role of general practitioners in BCG vaccination programs.

Main Methods:

  • Literature review of BCG vaccination practices and evidence.
  • Analysis of current Australian guidelines for BCG use.
  • Synthesis of data on BCG efficacy and safety.

Main Results:

  • BCG vaccination in Australia primarily targets neonates and children at high risk of TB exposure.
  • The vaccine is most effective in preventing severe disseminated TB in young children, with variable efficacy in adults.
  • BCG is generally well-tolerated, but requires experienced administration due to rare adverse effects.

Conclusions:

  • BCG vaccination is indicated for specific high-risk pediatric groups in Australia.
  • General practitioners should be aware of BCG indications, contraindications, and administration protocols.
  • Access to BCG vaccine in Australia is typically through specialist TB or travel medicine centers.